Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM)

被引:76
作者
Feng, SS
Ruan, G
Li, QT
机构
[1] Natl Univ Singapore, Fac Engn, Dept Chem & Environm Engn, Singapore 119260, Singapore
[2] Natl Univ Singapore, Div Bioengn, Singapore 119260, Singapore
[3] Natl Univ Singapore, Fac Med, Dept Biochem, Singapore 119260, Singapore
关键词
biodegradable polymers; controlled drug delivery; phospholipid bilayer vesicles; pulsatile drug release; chitosan;
D O I
10.1016/j.biomaterials.2003.12.013
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the present work, we developed a novel drug delivery system, liposomes-in-microsphere (LIM) of biodegradable polymers, which is conceived from a combination of the polymer- and the lipid-based delivery systems and can thus integrate the advantages and avoid the drawbacks of the two systems. Liposomes were encapsulated into microspheres of biodegradable polymers by the solvent extraction evaporation process to form LIMs. The integrity of the liposomes was preserved by modifying the microencapsulation process and coating the liposomes with chitosan. We demonstrated by scanning electron microscopy, laser light scattering and fluorescence spectroscopy that the particle size and surface morphology of the polymeric microspheres did not change significantly with the liposomes encapsulated, the liposomes remained intact within the polymeric matrix of the microspheres. and the encapsulated liposomes could be released from the microspheres in a controlled manner at a nearly constant release rate after an initial off-release period. Decreasing the particle size of liposomes and increasing the pore size of the polymeric matrix shortened the initial off-release period and increased the liposome release rate. In conclusion, a novel drug delivery system. liposomes-in-microsphere, was successfully developed and characterized. The liposome release kinetics could be controlled by the composition and fabrication parameters of the liposomes and polymeric microspheres. Such a novel controlled release system may have potential to be applied for drug delivery and gene therapy. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5181 / 5189
页数:9
相关论文
共 31 条
  • [1] Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel
    Ceruti, M
    Crosasso, P
    Brusa, P
    Arpicco, S
    Dosio, F
    Cattel, L
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) : 141 - 153
  • [2] Chen ZY, 2003, MOL THER, V7, pS64
  • [3] Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes
    Crosasso, P
    Ceruti, M
    Brusa, P
    Arpicco, S
    Dosio, F
    Cattel, L
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) : 19 - 30
  • [4] Dass CR, 1999, DRUG DELIV, V6, P243
  • [5] Dorr R. T., 1994, ANN PHARMACOTHER, V28, pS11
  • [6] Fan L., 1989, Controlled release: A quantitative treatment
  • [7] Nanoparticles of biodegradable polymers for clinical administration of paclitaxel
    Feng, SS
    Mu, L
    Win, KY
    Huang, GF
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (04) : 413 - 424
  • [8] Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers
    Feng, SS
    Huang, GF
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) : 53 - 69
  • [9] IS CREMOPHOR EL, SOLVENT FOR PACLITAXEL, CYTOTOXIC
    FJALLSKOG, ML
    FRII, L
    BERGH, J
    [J]. LANCET, 1993, 342 (8875) : 873 - 873
  • [10] Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
    Fonseca, C
    Simoes, S
    Gaspar, R
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (02) : 273 - 286